Enhanced anti-mammary gland cancer activities of tamoxifen-loaded erythropoietin-coated drug delivery system.
Nanomedicine is an emerging area in the medical field, particularly in the treatment of cancers. Nanostructured lipid carrier (NLC) was shown to be a good nanoparticulated carrier for the delivery of tamoxifen (TAM). In this study, the tamoxifen-loaded erythropoietin-coated nanostructured lipid carr...
Main Authors: | Chaw Yee Beh, Abdullah Rasedee, Gayathri Thevi Selvarajah, Latifah Saiful Yazan, Abdul Rahman Omar, Jia Ning Foong, Chee Wun How, Jhi Biau Foo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0219285 |
Similar Items
-
Development of erythropoietin receptor-targeted drug delivery system against breast cancer using tamoxifen-loaded nanostructured lipid carriers
by: Beh CY, et al.
Published: (2017-03-01) -
Zerumbone-Loaded Nanostructured Lipid Carrier Induces Apoptosis of Canine Mammary Adenocarcinoma Cells
by: Jia Ning Foong, et al.
Published: (2018-01-01) -
Recombinant human Erythropoietin enhanced the cytotoxic effects of tamoxifen toward the spheroid MCF-7 breast cancer cells
by: Hareth Y. Shujaa Edin, et al.
Published: (2021-09-01) -
Study of the action of tamoxifen on the mammary gland epithelium of premenopausal patients by lysosome quantification
by: Carlos ltio Tanaka, et al. -
Effect of fetal bovine serum on erythropoietin receptor expression and viability of breast cancer cells
by: Guan-Young Teo, et al.
Published: (2020-02-01)